chr7-143222226-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_176882.2(TAS2R40):c.148G>A(p.Gly50Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_176882.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R40 | NM_176882.2 | c.148G>A | p.Gly50Ser | missense_variant | 1/1 | ENST00000408947.4 | NP_795363.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R40 | ENST00000408947.4 | c.148G>A | p.Gly50Ser | missense_variant | 1/1 | 6 | NM_176882.2 | ENSP00000386210.3 | ||
ENSG00000268170 | ENST00000595842.2 | n.42C>T | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249162Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135158
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461808Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727194
GnomAD4 genome AF: 0.000118 AC: 18AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.148G>A (p.G50S) alteration is located in exon 1 (coding exon 1) of the TAS2R40 gene. This alteration results from a G to A substitution at nucleotide position 148, causing the glycine (G) at amino acid position 50 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at